Stay updated on PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The clinical trial record for the study of pembrolizumab combined with NK immunotherapy is displayed, including its design, participant criteria, interventions, outcome measures, and study history.
    Difference
    40%
    Check dated 2026-11-07T11:40:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T11:57:57.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence,” with both terms appearing during the transition. It appears above the unavailable study record.
    Difference
    1%
    Check dated 2026-10-24T11:41:35.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2; the study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T12:22:16.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1; the page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T12:23:40.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, blocking access to the study record and making the study details inaccessible.
    Difference
    17%
    Check dated 2026-09-19T20:20:21.000Z thumbnail image

Stay in the know with updates to PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD-1 and NK Immunotherapy Combo in Solid Tumors Clinical Trial page.